Why Nautilus Biotechnology, Inc. (NAUT) stock fell 13.1% on Friday, October 30, 2026

Nautilus Biotechnology, Inc. (NAUT) closed at $2.73, down 13.06% on Friday, October 30, 2026, on volume of 7,984,731 shares (1.5× its 3-month average); market value about $300.0M.

What happened

Nexqual found no SEC filing, earnings release, analyst rating change or insider trade for NAUT on Friday, October 30, 2026 or October 29, 2026. The move may reflect news, sector or market moves, or trading flows that these sources do not capture.

More on NAUT

NAUT stock page: price, SEC financials, insider trades, superinvestor holders, analyst estimates and options. Other big moves that day: October 30, 2026.

Sources: SEC EDGAR, Nexqual Earnings Flash, analyst rating changes, Nexqual market data. Built November 4, 2026 at 11:37 UTC. Not investment advice.

Data source: Nexqual. Last updated: November 4, 2026 at 11:37 UTC. This page is informational and not investment advice.

For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt